Kyowa Kirin Co Ltd's Fiscal Year is From January To December - All Figures are in JPY, Billions.
The item "Operating-Income" stands at 84.30 Billion Japanese Yens for the trailing twelve months (TTM) period ending 06/30/2025, the lowest value since 12/31/2023.
Kyowa Kirin Co Ltd's second quarter result of 23.93 Billion JPY for the item "Operating Income" represents an increase of 150.96 percent compared to it's first quarter result.
Also, Kyowa Kirin Co Ltd's second quarter result of 23.93 Billion JPY for the item "Operating Income" represents a decrease of -2.47 percent compared to it's second quarter result of last year.
Looking again at the trailing twelve months series (TTM), Kyowa Kirin Co Ltd's second quarter result of 84.30 Billion JPY for the item "Operating Income" represents a decrease of -0.71 percent compared to it's first quarter result.
Regarding the One-Year-Change of the series, the current value constitutes a decrease of -16.36 percent compared to the value the year prior.
The 1 year change in percent is -16.36.
The 3 year change in percent is 18.45.
The 5 year change in percent is 54.87.
The 10 year change in percent is 109.54.
| Logo | Name | Market Cap (USD) |
|---|---|---|
![]() | Eli Lilly and Company - Operating Income | 905,699,262,464.00 |
![]() | Johnson & Johnson - Operating Income | 486,508,953,600.00 |
![]() | AbbVie Inc - Operating Income | 399,570,305,024.00 |
![]() | Roche Holding AG - Operating Income | 317,433,206,677.55 |
![]() | AstraZeneca PLC - Operating Income | 280,205,508,085.11 |